eli lilly retatrutide phase 3 trial 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in New Phase 3 TRIUMPH-1 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most Eli Lilly just announced striking
Description
Nowacka, A., niegocka, M., niegocki, M., Zikowska, E., Boiow, D., & Smuczyski, W
Sharma et al., 2013)
Great oversight, sure, but nowhere near the same strict federal manufacturing rules as big pharma
Low-cost solution for rodent home-cage behaviour monitoring
Who will benefit, payers or patients, and in what ways
Some patients pursue out-of-network reimbursement for FDA-approved branded medications, but the compounded tablet path is generally not covered
